Compare Organon Pharma Indonesia Tbk. (SCPI) vs Jaya Swarasa Agung Tbk. (TAYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Jaya Swarasa Agung Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Jaya Swarasa Agung Tbk. trades at Rp50 (market cap 54.95B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | TAYS | |
|---|---|---|
Market Cap | 104.4B | 54.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Jaya Swarasa Agung Tbk.
PT Jaya Swarasa Agung Tbk (the Company) was established based on Notarial Deed No. 4 dated May 1, 1998 of Trinawati Mulia, S.H., in Jakarta and has received approval as a legal entity from the Minister of Justice and Human Rights of the Republic from Indonesia dated July 19, 1999 through its Decision Letter No.C-13163.01.01.TH.99. The Company started its commercial operation in 1998.
Read more on TAYS →
